✨ Free AI Report
Prestige Consumer Healthcare Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Prestige Consumer Healthcare Inc.
Company Research

Prestige Consumer Healthcare Inc.: Business Overview, Financials & Competitive Analysis

Prestige Consumer Healthcare develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in North America, Australia, and internationally through two segments: Nort...

Analyst-debate audio for Prestige Consumer Healthcare Inc.

AskCyborg analysts argue the bull and bear cases for Prestige Consumer Healthcare Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Prestige is a stable OTC healthcare company with trusted brands and analyst support, but faces modest growth dynamics and recent...

Read the full analyst-debate transcript →
Industry Over-the-Counter (OTC) Healthcare and Consumer Healthcare Products
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Prestige Consumer Healthcare Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Prestige Consumer Healthcare Inc. Overview

Pro stress-test →

Prestige Consumer Healthcare develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in North America, Australia, and internationally through two segments: North American OTC Healthcare and International OTC Healthcare. The company owns iconic brands like Dramamine, Fleet, Gaviscon, Monistat, and Summer's Eve, reaching consumers through mass merchandisers, drug stores, dollar stores, and e-commerce channels.

Strategic Profile

Pro stress-test →

In fiscal year 2025, PBH's revenue was $1.14 billion, an increase of 1.10% compared to the previous year. According to 5 analysts, the average rating for PBH stock is "Buy" with a 12-month stock price target of $85.4, representing a 27.86% upside from current levels. The company's competitive advantage lies in its diversified portfolio of trusted OTC healthcare brands with established distribution networks.

Competitive Landscape

Pro stress-test →

Prestige competes in the OTC consumer healthcare market against companies like Church & Dwight (Arm & Hammer), Reckitt Benckiser, and Procter & Gamble (Vicks). The company differentiates through its diversified portfolio of established brands with strong consumer recognition and efficient distribution networks across retail and e-commerce channels.

Industry Context

Prestige Consumer Healthcare Inc. operates in Over-the-Counter (OTC) Healthcare and Consumer Healthcare Products.

Key facts

Founded: 1996 · Headquarters: Tarrytown, New York · Revenue: $1.14B · Market cap: $2.97B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Prestige Consumer Healthcare Inc..

  • Prestige operates a diverse portfolio including DenTek dental products, Dramamine motion sickness relief, Fleet laxatives, Gaviscon stomach remedies, Luden's cough drops, Monistat yeast infection treatments, and Summer's Eve feminine care products.
  • Q2 2026 results showed strong execution with EPS of $1.07 (10.31% beat) and revenue of $274.11M (6.87% beat).
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Q3 fiscal 2026 financial results reported for nine months ended December 31, 2025
  • January 2026Q1 fiscal 2026 earnings announcement with $249.5M revenue amid eye care supply constraints
  • +1 moreTrack every material event for Prestige Consumer Healthcare Inc. as it happens. Explore monitoring →
Get alerted when Prestige Consumer Healthcare Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

OTC Cold & Cough ProductsVicks brand cough and cold remedies→Household Care ProductsArm & Hammer baking soda and consumer health products→OTC Healthcare PortfolioBroad OTC health and hygiene products portfolio→

Compare Prestige Consumer Healthcare Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Prestige Consumer Healthcare Inc. operates in Over-the-Counter (OTC) Healthcare and Consumer Healthcare Products. See how the rest of the sector scores on the Cyborg framework.

Browse Over-the-Counter (OTC) Healthcare and Consumer Healthcare Products research →
NEW · MCP server

Ask your AI assistant about Prestige Consumer Healthcare Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Prestige Consumer Healthcare Inc. and its top competitor on Cyborg Score”
“What did Prestige Consumer Healthcare Inc. do this quarter?”
“Is Prestige Consumer Healthcare Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Prestige Consumer Healthcare Inc. do?+
Prestige Consumer Healthcare develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in North America, Australia, and internationally through two segments: Nort...
What is Prestige Consumer Healthcare Inc.'s Cyborg Score?+
Prestige Consumer Healthcare Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Prestige Consumer Healthcare Inc.'s main competitors?+
Named competitors include OTC Cold & Cough Products, Household Care Products, OTC Healthcare Portfolio. The full competitive landscape is in the AskCyborg report.
How can I get the full Prestige Consumer Healthcare Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Prestige Consumer Healthcare Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Prestige Consumer Healthcare Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.